207 related articles for article (PubMed ID: 35039463)
1. CD161 expression and regulation defines rapidly responding effector CD4+ T cells associated with improved survival in HPV16-associated tumors.
Duurland CL; Santegoets SJ; Abdulrahman Z; Loof NM; Sturm G; Wesselink TH; Arens R; Boekestijn S; Ehsan I; van Poelgeest MIE; Finotello F; Hackl H; Trajanoski Z; Ten Dijke P; Braud VM; Welters MJP; van der Burg SH
J Immunother Cancer; 2022 Jan; 10(1):. PubMed ID: 35039463
[TBL] [Abstract][Full Text] [Related]
2. CD161 defines a transcriptional and functional phenotype across distinct human T cell lineages.
Fergusson JR; Smith KE; Fleming VM; Rajoriya N; Newell EW; Simmons R; Marchi E; Björkander S; Kang YH; Swadling L; Kurioka A; Sahgal N; Lockstone H; Baban D; Freeman GJ; Sverremark-Ekström E; Davis MM; Davenport MP; Venturi V; Ussher JE; Willberg CB; Klenerman P
Cell Rep; 2014 Nov; 9(3):1075-88. PubMed ID: 25437561
[TBL] [Abstract][Full Text] [Related]
3. The c.503T>C Polymorphism in the Human KLRB1 Gene Alters Ligand Binding and Inhibitory Potential of CD161 Molecules.
Rother S; Hundrieser J; Pokoyski C; Kollrich S; Borns K; Blasczyk R; Poehnert D; Klempnauer J; Schwinzer R
PLoS One; 2015; 10(8):e0135682. PubMed ID: 26309225
[TBL] [Abstract][Full Text] [Related]
4. C-type lectin-like CD161 is not a co-signalling receptor in gluten-reactive CD4 + T cells.
Wyrożemski Ł; Sollid LM; Qiao SW
Scand J Immunol; 2021 Jun; 93(6):e13016. PubMed ID: 33368526
[TBL] [Abstract][Full Text] [Related]
5. Longitudinal Analysis of Peripheral and Colonic CD161
Lal KG; Phuang-Ngern Y; Suhkumvittaya S; Leeansyah E; Alrubayyi A; Dias J; Waickman A; Kim D; Kroon E; Pinyakorn S; Eller LA; Maciel M; Rerknimitr R; Chomchey N; Phanuphak N; de Souza MSS; Nitayaphan S; Ake JA; Vasan S; Robb ML; Ananworanich J; Sandberg JK; Schuetz A; Eller MA; Paquin-Proulx D
Viruses; 2020 Dec; 12(12):. PubMed ID: 33322496
[TBL] [Abstract][Full Text] [Related]
6. KLRB1 defines an activated phenotype of CD4+ T cells and shows significant upregulation in patients with primary Sjögren's syndrome.
Zhang Z; Bahabayi A; Liu D; Hasimu A; Zhang Y; Guo S; Liu R; Zhang K; Li Q; Xiong Z; Wang P; Liu C
Int Immunopharmacol; 2024 May; 133():112072. PubMed ID: 38636371
[TBL] [Abstract][Full Text] [Related]
7. A CD4+CD161+ T-Cell Subset Present in Unexposed Humans, Not Tb Patients, Are Fast Acting Cells That Inhibit the Growth of Intracellular Mycobacteria Involving CD161 Pathway, Perforin, and IFN-γ/Autophagy.
Yang R; Peng Y; Pi J; Liu Y; Yang E; Shen X; Yao L; Shen L; Modlin RL; Shen H; Sha W; Chen ZW
Front Immunol; 2021; 12():599641. PubMed ID: 33732233
[TBL] [Abstract][Full Text] [Related]
8. Increased frequency of CD4+ cells expressing CD161 in cancer patients.
Iliopoulou EG; Karamouzis MV; Missitzis I; Ardavanis A; Sotiriadou NN; Baxevanis CN; Rigatos G; Papamichail M; Perez SA
Clin Cancer Res; 2006 Dec; 12(23):6901-9. PubMed ID: 17145807
[TBL] [Abstract][Full Text] [Related]
9. CD161 Characterizes an Inflamed Subset of Cytotoxic T Lymphocytes Associated with Prolonged Survival in Human Papillomavirus-Driven Oropharyngeal Cancer.
Wei Y; Xu T; Li C; Zhou X; Qian W; Shen C; Wang Q; Xing X; Ou X; He X; Yin H; Hu C; Wang Y; Ji Q; Su F; Lu X
Cancer Immunol Res; 2023 Mar; 11(3):306-319. PubMed ID: 36633583
[TBL] [Abstract][Full Text] [Related]
10. Intratumoral HPV16-Specific T Cells Constitute a Type I-Oriented Tumor Microenvironment to Improve Survival in HPV16-Driven Oropharyngeal Cancer.
Welters MJP; Ma W; Santegoets SJAM; Goedemans R; Ehsan I; Jordanova ES; van Ham VJ; van Unen V; Koning F; van Egmond SI; Charoentong P; Trajanoski Z; van der Velden LA; van der Burg SH
Clin Cancer Res; 2018 Feb; 24(3):634-647. PubMed ID: 29018052
[No Abstract] [Full Text] [Related]
11. CD161 is a marker of all human IL-17-producing T-cell subsets and is induced by RORC.
Maggi L; Santarlasci V; Capone M; Peired A; Frosali F; Crome SQ; Querci V; Fambrini M; Liotta F; Levings MK; Maggi E; Cosmi L; Romagnani S; Annunziato F
Eur J Immunol; 2010 Aug; 40(8):2174-81. PubMed ID: 20486123
[TBL] [Abstract][Full Text] [Related]
12. Age and CD161 expression contribute to inter-individual variation in interleukin-23 response in CD8+ memory human T cells.
Shen H; Zhang W; Abraham C; Cho JH
PLoS One; 2013; 8(3):e57746. PubMed ID: 23469228
[TBL] [Abstract][Full Text] [Related]
13. Innate signals overcome acquired TCR signaling pathway regulation and govern the fate of human CD161(hi) CD8α⁺ semi-invariant T cells.
Turtle CJ; Delrow J; Joslyn RC; Swanson HM; Basom R; Tabellini L; Delaney C; Heimfeld S; Hansen JA; Riddell SR
Blood; 2011 Sep; 118(10):2752-62. PubMed ID: 21791427
[TBL] [Abstract][Full Text] [Related]
14. The Anatomical Location Shapes the Immune Infiltrate in Tumors of Same Etiology and Affects Survival.
Santegoets SJ; van Ham VJ; Ehsan I; Charoentong P; Duurland CL; van Unen V; Höllt T; van der Velden LA; van Egmond SL; Kortekaas KE; de Vos van Steenwijk PJ; van Poelgeest MIE; Welters MJP; van der Burg SH
Clin Cancer Res; 2019 Jan; 25(1):240-252. PubMed ID: 30224343
[TBL] [Abstract][Full Text] [Related]
15. Impact of Aging on the Frequency, Phenotype, and Function of CD161-Expressing T Cells.
van der Geest KSM; Kroesen BJ; Horst G; Abdulahad WH; Brouwer E; Boots AMH
Front Immunol; 2018; 9():752. PubMed ID: 29725326
[TBL] [Abstract][Full Text] [Related]
16. CD161(high)CD8+T cells bear pathogenetic potential in multiple sclerosis.
Annibali V; Ristori G; Angelini DF; Serafini B; Mechelli R; Cannoni S; Romano S; Paolillo A; Abderrahim H; Diamantini A; Borsellino G; Aloisi F; Battistini L; Salvetti M
Brain; 2011 Feb; 134(Pt 2):542-54. PubMed ID: 21216829
[TBL] [Abstract][Full Text] [Related]
17. A subset of virus-specific CD161
Alsuliman A; Muftuoglu M; Khoder A; Ahn YO; Basar R; Verneris MR; Muranski P; Barrett AJ; Liu E; Li L; Stringaris K; Armstrong-James D; Shaim H; Kondo K; Imahashi N; Andersson B; Marin D; Champlin RE; Shpall EJ; Rezvani K
Blood; 2017 Feb; 129(6):740-758. PubMed ID: 27821506
[TBL] [Abstract][Full Text] [Related]
18. Clinical relevance of RORγ positive and negative subsets of CD161+CD4+ T cells in primary Sjögren's syndrome.
Zhao L; Nocturne G; Haskett S; Boudaoud S; Lazure T; Le Pajolec C; Mariette X; Mingueneau M; Banerjee D
Rheumatology (Oxford); 2017 Feb; 56(2):303-312. PubMed ID: 27803305
[TBL] [Abstract][Full Text] [Related]
19. Analysis of stem-cell-like properties of human CD161++IL-18Rα+ memory CD8+ T cells.
Havenith SH; Yong SL; Henson SM; Piet B; Idu MM; Koch SD; Jonkers RE; Kragten NA; Akbar AN; van Lier RA; ten Berge IJ
Int Immunol; 2012 Oct; 24(10):625-36. PubMed ID: 22836020
[TBL] [Abstract][Full Text] [Related]
20. Decreased levels of circulating IL17-producing CD161+CCR6+ T cells are associated with graft-versus-host disease after allogeneic stem cell transplantation.
van der Waart AB; van der Velden WJ; van Halteren AG; Leenders MJ; Feuth T; Blijlevens NM; van der Voort R; Dolstra H
PLoS One; 2012; 7(12):e50896. PubMed ID: 23226545
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
